These findings highlight that shRNA-mediated CCR3 inhibition effectively attenuates mast cell migration, infiltration, and degranulation in local tissues, thereby reducing inflammation in allergic rhinitis mice. The gene discussed is CCR3; the disease is allergic rhinitis.